Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems

Contraception

Volumn 87, Issue 3, 2013, Pages 273-279

  Fraser, Ian S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Contraception; Health benefits; Hormonal delivery systems; Intrauterine hormonal system

Indexed keywords

ESTROGEN; ETYNODIOL DIACETATE PLUS MESTRANOL; GESTAGEN; IRON; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE; TAMOXIFEN; TRANEXAMIC ACID;

ACNE; ADENOMYOSIS; ANEMIA; ANOVULATION; BIRTH CONTROL; CONFERENCE PAPER; CONTRACEPTION; DRUG MEGADOSE; DRUG SAFETY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ESTROGEN THERAPY; FEMALE FERTILITY; FEMALE INFERTILITY; HEAVY MENSTRUAL BLEEDING; HEAVY MESTRUAL BLEEDING; HORMONAL CONTRACEPTION; HUMAN; IRON DEFICIENCY; LIFESPAN; MENSTRUATION DISORDER; OVARY CANCER; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; RISK REDUCTION; SEBORRHEA; TRANSDERMAL PATCH; UTERUS MYOMA; VAGINA RING;

CONTRACEPTIVE AGENTS, FEMALE; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL;

EID: 84873412587     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.08.039     Document Type: Conference Paper

References (85)

1. R. Sitruk-Ware Contraceptive technology: past, present and future Contraception 2012 this volume
2. V.A. Drill History of the first oral contraceptive J Toxicol Environ Health 3 1977 133 138
3. P.M.F. Bishop Treatment of functional menstrual disorders with norethisterone Br Med J 9 1960 1103 1105
4. R.W. Kistner Treatment of hyperplasia and carcinoma of the endometrium Clin Obstet Gynecol 25 1982 63 74
5. D.R. Mishell Jr. Noncontraceptive health benefits of oral steroidal contraceptives Am J Obstet Gynecol 142 6 II 1982 809 816
6. R. Burkman, J.J. Schlesselman, and M. Zieman Safety concerns and health benefits associated with oral contraception Am J Obstet Gynecol 190 2004 S5 S22
7. L.P. Shulman The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives AJOG 205 4 suppl 2011 S9 S13
8. The ESHRE Capri Workshop Group Non-contraceptive health benefits of combined oral contraception Hum Reprod Update 11 2005 513 525
9. M. Vessey, D. Yeates, and S. Flynn Factors affecting mortality in a large cohort study with special reference to oral contraceptive use Contraception 82 2010 221 229
10. I.S. Fraser The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease Contraception 75 Suppl. 6 2007 S112 S117
11. I.S. Fraser Non-contraceptive health benefits of intrauterine health systems Contraception 82 2010 396 403
12. L. Bahamondes, M.V. Bahamondes, and I. Monteiro Levonorgestrel-releasing intrauterine system: uses and controversies Expert Rev Med Dev 5 2008 437 445
13. A.E. Burke The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives Am J Obstet Gynecol 205 4 suppl 2011 S14 S17
14. O. Heikinheimo, and K. Gemzell-Danielsson Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS) Acta Obstet Gynecol Scand 91 2012 3 9
15. T. Luukkainen The levonorgestrel-releasing IUD Br J Fam Plan 19 1993 221 224
16. D. Wildemeersch, and P.J. Rowe Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system Contraception 70 2004 165 168
17. D. Wildemeersch, and P.J. Rowe Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system Contraception 71 2005 470 473
18. S. Eaton, M.C. Pike, and R.V. Short Women's reproductive cancers in evolutionary context Quart Rev Biol 69 1994 353 367
19. K. Andersson, and G. Rybo Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia Br J Obstet Gynaecol 97 1990 690 694
20. M. Dueholm Levonorgestrel-IUD should be offered before hysterectomy for abnormal uterine bleeding without uterine structural abnormalities: there are no more excuses! Acta Obstet Gynecol Scand 88 2009 1302 1304
21. A. Kaunitz, and P. Inki The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a risk-benefit review Drugs 72 2012 193 215
22. M.M. Shabaan, M.S. Zakherah, S.A. El-Nashar, and G.H. Sayed Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial Contraception 83 2011 48 54
23. J. Endrikat, H. Shapiro, and E. Lukkari-Lax A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia JOGC 31 2009 340 347
24. D. Chelmow Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial Obstet Gynecol 116 2010 1455 1456
25. J. Marjoribanks, A. Lethaby, and C. Farquhar Surgery versus medical therapy for heavy menstrual bleeding Cochrane Database Syst Rev 2 2006
26. National Institute for Health Clinical Excellence Long-acting reversible contraception 2005 National Collaborating Centre for Women's and Children's Health London
27. J. Jensen, S. Parke, U. Mellinger, A. Machlitt, and I.S. Fraser Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest Obstet Gynecol 117 2011 777 787
28. I.S. Fraser, T. Romer, and S. Parke Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing oestradiol valerate and dienogest: a randomised, double-blind and placebo-controlled phase III trial Hum Reprod 26 2011 2698 2708
29. A.M. Kaunitz, S. Meredith, P. Inki, A. Kubba, and L. Sanchez-Ramos Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis Obstet Gynecol 113 2009 1104 1116
30. A.M. Kaunitz Progestin-releasing intrauterine systems and leiomyoma Contraception 75 6 suppl 2007 S130 S133
31. F. Mercorio, R. De Simone, and A. Di Spiezio Sardo The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia Contraception 67 2003 277 280
32. V. Grigorieva, M. Chen-Mok, M. Tarasova, and A. Mikhailov Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Fertil Steril 79 2003 1194 1198
33. S. Soysal, and M.E. Soysal The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial Gynecol Obstet Invest 59 2005 29 35
34. G.H. Sayed, M.S. Zakherah, S.A. El-Nashar, and M.M. Shaaban A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia Int J Gynecol Obstet 112 2011 126 130
35. J. Magalhães, J.M. Aldrighi, and G.R. de Lima Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas Contraception 75 2007 193 198
36. B. Xiao, S.C. Wu, and J. Chong Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia Fertil Steril 79 2003 963 969
37. A. Kriplani, B.M. Singh, S. Lal, and N. Agarwal Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia Int J Gynecol Obstet 97 2007 190 194
38. L. Fedele, A. Portuese, S. Bianchi, M. Dorta, and R. Raffaelli Treatment of adenomyosis-associated menorrhagia with a levonorgestrel- releasing intrauterine device Fertil Steril 68 1997 426 429
39. A.M. Bragheto, N. Caserta, L. Bahamondes, and C.A. Petta Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging Contraception 76 2007 195 199
40. S. Cho, A. Nam, and H. Kim Clinical effects of the levonorgestrel- releasing intrauterine device in patients with adenomyosis Am J Obstet Gynecol 198 2008 373.e1 373.e7
41. Y.F. Fong, and K. Singh Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system Contraception 60 1999 173 175
42. J. Sheng, W.Y. Zhang, J.P. Zhang, and D. Lu The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis Contraception 79 2009 189 193
43. R.A. Kadir, and C. Chi Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy Contraception 75 6 suppl 2007 S123 S129
44. C.E.C. Kingman, R.A. Kadir, C.A. Lee, and D.L. Economides The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders BJOG 111 12 2004 1425 1428
45. Z.E. Schaedel, G. Dolan, and M.C. Powell The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders Am J Obstet Gynecol 193 2005 1361 1363
46. A.S. Lukes, B. Reardon, and G. Arepally Use of the levonorgestrel- releasing intrauterine system in women with hemostatic disorders Fertil Steril 90 2008 673 677
47. G.A. Vilos, V. Tureanu, M. Garcia, and B. Abu-Rafea The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy J Minim Invasive Gynecol 16 2009 480 484
48. K.R. Culwell, and K.M. Curtis Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review Contraception 80 2009 337 345
49. C. Chi, F.Y. Huq, and R.A. Kadir Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up Contraception 83 2011 242 247
50. H.T. Depypere, T. Hillard, and R. Erkkola A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause Eur J Obstet Gynecol Reprod Biol 153 2010 176 180
51. G.A. Vilos, J. Marks, V. Tureanu, B. Abu-Rafea, and A.G. Vilos The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding J Minim Invasive Gynecol 18 2011 75 80
52. F. Imperato, G. Perniola, and B. Mossa The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecol 54 2002 271 278
53. L. Wang, G. Zhao, and L. Chen Investigation on the prevalence and influencing factors to anemia in women at reproductive age Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chin J Epidemiol 20 1999 158 161
54. R. Varma, H. Soneja, and K. Bhatia The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia - a long-term follow-up study Eur J Obstet Gynecol Reprod Biol 139 2008 169 175
55. A. Orbo, M. Arnes, and C. Hancke Treatment results of endometrial hyperplasia after prospective D-score classification. A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only Gynecol Oncol 111 2008 68 73
56. A. Orbo, C.E. Rise, and G.L. Mutter Regression of latent endometrial precancers by progestin infiltrated intrauterine device Cancer Res 66 2006 5613 5617
57. L. Bahamondes, P. Ribeiro-Huguet, K.C. De Andrade, O. Leon-Martins, and C.A. Petta Levonorgestrel-releasing intrauterine system (Mirena®) as a therapy for endometrial hyperplasia and carcinoma Acta Obstet Gynecol Scand 82 2003 580 582
58. M.J. Buttini, S.J. Jordan, and P.M. Webb The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review ANZJOG 49 2009 316 322
59. I.D. Gallos, M. Shehmar, and S. Thangaratinam Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis AJOG 203 2010 547.e1 547.e10
60. Y.L. Wan, and C. Holland The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review Climacteric 14 2011 622 632
61. F.J.E. Gardner, J.C. Konje, and S.C. Bell Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system. Long-term follow-up of a randomised control trial Gynecol Oncol 114 2009 452 456
62. P. Vercellini, G. Aimi, and S. Panazza A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study Fertil Steril 72 1999 505 508
63. L. Bahamondes, C.A. Petta, A. Fernandes, and I. Monteiro Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea Contraception 75 6 suppl 2007 S134 S139
64. C.A. Petta, R.A. Ferriani, and M.S. Abrao Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis Hum Reprod 20 2005 1993 1998
65. D. Alhamdan, T. Bignardi, G. Hardas, H. Merkur, and G. Condous Mirena intrauterine system: does it improve long-term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial Rev Recent Clin Trials 5 2010 143 146
66. R. Matorras, A. Ballesteros, and B. Prieto Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis J Reprod Med 56 2011 497 503
67. Y. Bayoglu Tekin, B. Dilbaz, S.K. Altinbas, and S. Dilbaz Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue Fertil Steril 95 2011 492 496
68. M. Rönnerdag, and V. Odlind Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use Acta Obstet Gynecol Scand 78 1999 716 721
69. I. Lete, M. Del Carme Cuesta, and J.M. Marín Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device? Eur J Obstet Gynecol Reprod Biol 154 2011 67 70
70. R. Hurskainen, J. Teperi, and P. Rissanen Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial Lancet 357 2001 273 277
71. P.C. Reid, and F. Mukri Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3 BMJ 330 2005 938 939
72. S. Heliövaara-Peippo, K. Halmesmäki, and R. Hurskainen The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial Acta Obstet Gynecol Scand 88 2009 1389 1396
73. O. Ozdegirmenci, F. Kayikcioglu, and M.A. Akgul Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis Fertil Steril 95 2011 497 502
74. A.Z. Goñi, R.L. Lacruz, J.J.P. Paricio, and F.J. Hernández Rivas The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia Gynecol Endocrinol 25 2009 581 586
75. A. Von Drygalski, and J.W. Adamson Ironing out fatigue Blood 118 2011 3191 3192
76. P. Vercellini, G. Frontino, and O. De Giorgi Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study Fertil Steril 80 2003 305 309
77. P. Tanmahasamut, M. Rattanachaiyanont, and S. Angsuwathana Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial Obstet Gynecol 119 2012 519 526
78. H. Paterson, J. Ashton, and M. Harrison-Woolrych A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents Contraception 79 2009 433 438
79. M. Pillai, K. O'Brien, and E. Hill The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities BJOG 117 2010 216 221
80. M. Al-Jefout, J. Palmer, and I.S. Fraser Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis ANZJOG 47 2007 247 249
81. C.G. Nilsson, M. Haukkamaa, H. Vierola, and T. Luukkainen Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD Clin Endocrinol 17 1982 529 536
82. N. Tokushige, R. Markham, P. Russell, and I.S. Fraser Effects of hormonal treatment on nerve fibres in endometrium and myometrium of women with endometriosis Fertil Steril 90 2008 1589 1598
83. N. Tokushige, R. Markham, P. Russell, and I.S. Fraser Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis Fertil Steril 92 2009 1234 1239
84. S.B. Yisa, A.A. Okenwa, and R.P. Husemeyer Treatment of pelvic endometriosis with the etonogestrel subdermal implant (Implanon) J Fam Plann Reprod Health Care 31 2005 67 70
85. I.S. Fraser, E. Weisberg, E. Minehan, and E.D.B. Johansson A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings Contraception 61 2000 241 251